94 related articles for article (PubMed ID: 22622106)
1. Thyroglobulin and recurrence of thyroid cancer.
Miwanitkit V
S Afr J Surg; 2012 Mar; 50(2):52. PubMed ID: 22622106
[No Abstract] [Full Text] [Related]
2. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
Feldt-Rasmussen U; Hansen HS; Rasmusson B
Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
[No Abstract] [Full Text] [Related]
3. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma.
Schlumberger M; Baudin E
Eur J Endocrinol; 1998 Mar; 138(3):249-52. PubMed ID: 9539294
[No Abstract] [Full Text] [Related]
4. Thyroglobulin - what is the postoperative threshold for the suspicion of thyroid cancer recurrence in the absence of anti-Tg antibody measurement?
Papageorgiou MS; Liratzopoulos N; Minopoulos G; Manolas KJ
S Afr J Surg; 2011 Aug; 49(3):118-22. PubMed ID: 21933495
[TBL] [Abstract][Full Text] [Related]
5. Monitoring for Thyroid Cancer Recurrence.
Peiris AN
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469905
[No Abstract] [Full Text] [Related]
6. Clinical and laboratory follow-up in differentiated thyroid carcinoma.
Maussier ML; Danese D; D'Errico G; Garganese MC; Pontecorvi A; Lemmo G
Rays; 2000; 25(2):239-44. PubMed ID: 11370541
[TBL] [Abstract][Full Text] [Related]
7. [Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].
Botsch H; Schulz E; Lochner B
Dtsch Med Wochenschr; 1979 Jul; 104(30):1072-4. PubMed ID: 467254
[TBL] [Abstract][Full Text] [Related]
8. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
[No Abstract] [Full Text] [Related]
9. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound?
Schlumberger M
Clin Endocrinol (Oxf); 2005 Feb; 62(2):119-20. PubMed ID: 15670184
[No Abstract] [Full Text] [Related]
10. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
[TBL] [Abstract][Full Text] [Related]
11. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
12. Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?
Tuttle RM
Endocrine; 2014 Aug; 46(3):363-4. PubMed ID: 24615658
[No Abstract] [Full Text] [Related]
13. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
[TBL] [Abstract][Full Text] [Related]
14. How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
Elisei R; Agate L; Viola D; Matrone A; Biagini A; Molinaro E
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):331-44. PubMed ID: 24891165
[TBL] [Abstract][Full Text] [Related]
15. [A case report of a giant cell carcinoma of the thyroid].
Murakami N; Kawaura Y; Sasaki M; Munemoto Y; Iwa T; Nonomura A
Gan No Rinsho; 1989 Jul; 35(8):927-32. PubMed ID: 2746867
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin level helps to predict recurrence after lobo-isthmusectomy in patients with differentiated thyroid carcinoma.
de Vathaire F; Blanchon S; Schlumberger M
Lancet; 1988 Jan 2-9; 1(8575-6):52-3. PubMed ID: 2891910
[No Abstract] [Full Text] [Related]
17. Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study.
Pelttari H; Välimäki MJ; Löyttyniemi E; Schalin-Jäntti C
Eur J Endocrinol; 2010 Nov; 163(5):757-63. PubMed ID: 20813788
[TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin in benign and malignant thyroid disease.
Gerfo PL; Colacchio T; Colacchio D; Feind C
JAMA; 1979 Mar; 241(9):923-4. PubMed ID: 762873
[TBL] [Abstract][Full Text] [Related]
19. A highly sensitive thyroglobulin assay has superior diagnostic sensitivity for recurrence of differentiated thyroid cancer in patients undergoing TSH suppression.
Zöphel K; Wunderlich G; Kotzerke J
J Nucl Med; 2006 Mar; 47(3):552-3; author reply 553. PubMed ID: 16513626
[No Abstract] [Full Text] [Related]
20. Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging
Okuyucu K; Ince S; Alagoz E; Emer O; San H; Balkan E; Ayan A; Meric C; Haymana C; Acıkel C; Gunalp B; Karacalioglu AO; Arslan N
Hell J Nucl Med; 2016; 19(3):208-217. PubMed ID: 27824959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
